Treatment of Moderate-to-Severe Glabellar Lines With RelabotulinumtoxinA, an Investigational Liquid Botulinum Toxin: Clinical Efficacy and Safety Results From the READY-1 Phase 3 Trial
Authors:
- Nowell SolishNSNowell Solish
- Amir MoradiAMAmir Moradi
- Sachin ShridharaniSSSachin Shridharani
- Lisa DonofrioLDLisa Donofrio
- Michael H GoldMGMichael H Gold
- Brian BiesmanBBBrian Biesman
- Melissa ChiangMCMelissa Chiang
- Rosalyn GeorgeRGRosalyn George
- Kristel PolderKPKristel Polder
- Rob SchwarczRSRob Schwarcz
- Xiaoming LinXLXiaoming Lin
- Sarah Coquis-KnezekSCSarah Coquis-Knezek
Abstract
No abstract availableKeywords
This publication has 1 reference indexed in Scilit: